Clinical Gastroenterology and Hepatology
Volume 7, Issue 9 , Pages 921-930, September 2009

Treatment Options for Patients With Chronic Hepatitis C Not Responding to Initial Antiviral Therapy

  • Ira M. Jacobson

      Affiliations

    • Corresponding Author InformationReprint requests Address requests for reprints to: Ira M. Jacobson, MD, Weill Cornell Medical College, 1305 York Avenue, New York, New York 10021; fax: (646) 962-0355

published online 13 April 2009.

Full Text Available

  • Purchase this article for  31.50 USD

    Access is available for 24 hours.

    (Login or Register to purchase)

  • Subscribe to this title
  • Claim access now

    Current subscribers


    •  Conflicts of interest The author discloses the following: Grant/research support: Anadys, Boehringer-Ingelheim, Dynavax, Gilead, GlobeImmune, Human Genome Sciences, Idenix, Merck, Novartis, Pfizer, Pharmasset, Schering-Plough, Valeant, and Vertex. Consultant/advisor: Anadys, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, Globelmmune, Human Genome Sciences, Idenix, InterMune, Merck, Novartis, Pfizer, Pharmasset, Roche, Schering-Plough, Vertex, and Zymogenetics. Speakers bureau: Bristol-Myers Squibb, Gilead, Idenix, Novartis, and Schering-Plough.

    PII: S1542-3565(09)00315-2

    doi:10.1016/j.cgh.2009.03.033

    Clinical Gastroenterology and Hepatology
    Volume 7, Issue 9 , Pages 921-930, September 2009